Health, Fitness & Food

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about 5.5% to start the week. Morgan Stanley reiterated Nvidia
0 Comments
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters LONDON — Popular weight-loss drug Wegovy could be made available under more health insurance schemes, after the results of a late-stage trial pointed to the drug’s efficacy in
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Back-to-back losses Still believe in Disney Eli Lilly keeps going 1. Back-to-back losses U.S. stocks on Wednesday were sinking for the second straight session ahead of this week’s key inflation
0 Comments
In this article LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023.  Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago Pharma, a privately held obesity drug maker, for up to $1.08 billion to broaden the Danish company’s blockbuster weight loss portfolio.  The deal is Novo Nordisk’s latest attempt to
0 Comments
In this article ILMN Follow your favorite stocksCREATE FREE ACCOUNT A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021. Mike Blake | Reuters The Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion acquisition of cancer test developer Grail, the DNA
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023.  Jim Vondruska | Reuters Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported
0 Comments
Organizers celebrate the defeat of Issue 1 during an election night party at the Columbus Fire Fighters Local 67 on Tuesday, Aug. 8, 2023 in Columbus, Ohio. Ohio voters have rejected a proposal that would’ve made it more difficult for voters to amend the state constitution, including one measure set for the November ballot that
0 Comments
In this article AMZN Follow your favorite stocksCREATE FREE ACCOUNT Amazon, the United States’ second-largest employer, will now offer fertility and family planning services to employees through a partnership with Maven Clinic. The free offering will be available to more than 1 million eligible Amazon employees spread across 50 countries outside of the U.S. and
0 Comments
In this article SAGE BIIB Follow your favorite stocksCREATE FREE ACCOUNT In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Sage Therapeutics fell more than 50% on Monday after the Food
0 Comments
In this article GSK-GB GSK PFE Follow your favorite stocksCREATE FREE ACCOUNT Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine.  GSK claims New York-based Pfizer’s RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen
0 Comments
In this article HUM Follow your favorite stocksCREATE FREE ACCOUNT A Humana office in Louisville, Kentucky, July 31, 2023. Jon Cherry | Bloomberg | Getty Images Humana shares rose Wednesday after the health insurer said medical costs came in lower than expected during its second-quarter earnings report. The results ease investor concerns two months after
0 Comments
In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue.  The biotech company generated second-quarter sales of
0 Comments